TYP 5.00% 1.9¢ tryptamine therapeutics limited

Ann: Exopharm Gains US Patent for LEAP Technology, page-25

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,139 Posts.
    lightbulb Created with Sketch. 1194
    Don't be fooled by a patent grant. Actually not that hard to achieve.

    I think this forum can benefit from contrarian voices if they make sense. But I think a patent granted in the US is a significant achievement. I think in fairness it actually shifts the burden of proof over to those saying the company hasn't got something of value to make that case wheras before the burden of proof was on the other side - because the patent is specific - its there inviting challenge.

    The text of the patent is linked in the other thread and there is an excerpt of the particular method claimed. Have you got anything to say that suggests that the grant of that particular patent in the US is somehow not significant? Because I'm inclined to believe that the USPTO did not just give away a patent to an Australian based applicant without doing some considering (there are 11 claims in the patent as published - fewer than what were proposed originally and what the Russians let through) and I see nothing to suggest that they made an error.
 
watchlist Created with Sketch. Add TYP (ASX) to my watchlist
(20min delay)
Last
1.9¢
Change
-0.001(5.00%)
Mkt cap ! $20.69M
Open High Low Value Volume
2.0¢ 2.0¢ 1.9¢ $18.75K 951.1K

Buyers (Bids)

No. Vol. Price($)
2 183839 1.9¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 1000000 1
View Market Depth
Last trade - 11.43am 11/10/2024 (20 minute delay) ?
TYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.